Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

October 24, 2024

Barclay Damon Attorneys Selected to 2024 New York Metro Super Lawyers and Rising Stars Lists

Barclay Damon had six attorneys selected to the 2024 New York Metro Super Lawyers list and six attorneys selected to the Rising Stars list.

Each year, no more than 5 percent of lawyers in the state are selected by the research team at Super Lawyers to receive the designation. Additionally, no more than 2.5 percent of the lawyers in the state are selected to receive the Rising Stars honor.

2024 New York Metro Super Lawyers honorees:

2024 New York Metro Rising Stars honorees:

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients' businesses. With nearly 300 attorneys, Barclay Damon is a leading regional law firm that operates from a strategic platform of offices in Albany, Boston, Buffalo, New Haven, New York City, Rochester, Syracuse, Washington DC, and Toronto. Our firm serves clients across the country and, for some practices, provides US legal services around the globe. For more information, visit our award-winning website at barclaydamon.com.
 

Featured Media

Alerts

NYS Governor Hochul's 2026 State of the State Address Signals Continued Focus on Nuclear Development, Announces Additional 4 GW Target

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 2

Alerts

College Sports Commission Issues Notice Regarding Violations Arising From Third-Party NIL Deals

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Antoinette Suchenko, Jared Charlap, Adrienne Beatty, Tracey Sinkovic, Dominick Petrillo, and Sofia Montano—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Second Department Holds CVA Plaintiff's Testimony of Repeated Classroom Abuse Sufficient to Raise Question of Fact as to Notice

Alerts

Shifting Drug Pricing Models: Independent Pharmacies Need to Develop Compliance Strategies Now